BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Farmen K, Nissen SK, Stokholm MG, Iranzo A, Østergaard K, Serradell M, Otto M, Svendsen KB, Garrido A, Vilas D, Borghammer P, Santamaria J, Møller A, Gaig C, Brooks DJ, Tolosa E, Pavese N, Romero-Ramos M. Monocyte markers correlate with immune and neuronal brain changes in REM sleep behavior disorder. Proc Natl Acad Sci U S A 2021;118:e2020858118. [PMID: 33658371 DOI: 10.1073/pnas.2020858118] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen Y, Zhao A, Lyu J, Hu Y, Yin Y, Qu J, Tong S, Li S. . NSS 2022;Volume 14:1559-73. [DOI: 10.2147/nss.s356182] [Reference Citation Analysis]
2 Liu SY, Qiao HW, Song TB, Liu XL, Yao YX, Zhao CS, Barret O, Xu SL, Cai YN, Tamagnan GD, Sossi V, Lu J, Chan P. Brain microglia activation and peripheral adaptive immunity in Parkinson's disease: a multimodal PET study. J Neuroinflammation 2022;19:209. [PMID: 36038917 DOI: 10.1186/s12974-022-02574-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Valli M, Uribe C, Mihaescu A, Strafella AP. Neuroimaging of rapid eye movement sleep behavior disorder and its relation to Parkinson's disease. J of Neuroscience Research. [DOI: 10.1002/jnr.25099] [Reference Citation Analysis]
4 Terkelsen MH, Klaestrup IH, Hvingelby V, Lauritsen J, Pavese N, Romero-Ramos M. Neuroinflammation and Immune Changes in Prodromal Parkinson's Disease and Other Synucleinopathies. J Parkinsons Dis 2022. [PMID: 35723115 DOI: 10.3233/JPD-223245] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Konstantin Nissen S, Farmen K, Carstensen M, Schulte C, Goldeck D, Brockmann K, Romero-Ramos M. Changes in CD163+, CD11b+, and CCR2+ peripheral monocytes relate to Parkinson's disease and cognition. Brain Behav Immun 2022;101:182-93. [PMID: 35026420 DOI: 10.1016/j.bbi.2022.01.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
6 Kasen A, Houck C, Burmeister AR, Sha Q, Brundin L, Brundin P. Upregulation of α-synuclein following immune activation: Possible trigger of Parkinson's disease. Neurobiology of Disease 2022. [DOI: 10.1016/j.nbd.2022.105654] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Sun H, Zhang X, Ma J, Liu Z, Qi Y, Fang L, Zheng Y, Cai Z. Circulating Soluble CD163: A Potential Predictor for the Functional Outcome of Acute Ischemic Stroke. Front Neurol 2021;12:740420. [PMID: 34970202 DOI: 10.3389/fneur.2021.740420] [Reference Citation Analysis]
8 Jiménez-Jiménez FJ, Alonso-Navarro H, García-Martín E, Agúndez JAG. Neurochemical Features of Rem Sleep Behaviour Disorder. J Pers Med 2021;11:880. [PMID: 34575657 DOI: 10.3390/jpm11090880] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Wallin J, Svenningsson P. Potential Effects of Leukotriene Receptor Antagonist Montelukast in Treatment of Neuroinflammation in Parkinson's Disease. Int J Mol Sci 2021;22:5606. [PMID: 34070609 DOI: 10.3390/ijms22115606] [Cited by in F6Publishing: 3] [Reference Citation Analysis]